Department of Otorhinolaryngology Head and Neck Surgery, Liaocheng People's Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Liaocheng, Shandong, China.
Department of Otorhinolaryngology, Heze Municipal Hospital, Heze, Shandong, China.
World J Surg Oncol. 2024 Sep 20;22(1):254. doi: 10.1186/s12957-024-03536-w.
Hypopharyngeal carcinoma is one of the malignant tumors of the head and neck with a particularly poor prognosis. Recurrence and metastasis are important reasons for poor prognosis of hypopharyngeal cancer patients, and malignant proliferation, migration, and invasion of tumor cells are important factors for recurrence and metastasis of hypopharyngeal cancer. Therefore, elucidating hypopharyngeal cancer cells' proliferation, migration, and invasion mechanism is essential for improving diagnosis, treatment, and prognosis. Plasmacytoma Variant Translocation 1 (PVT1) is considered a potential diagnostic marker and therapeutic target for tumors. However, it remains unclear whether PVT1 is related to the occurrence and development of hypopharyngeal cancer and its specific mechanism. In this study, the promoting effect of PVT1 on the proliferation, migration, and invasion of hypopharyngeal carcinoma FaDu cells was verified by cell biology experiments and animal studies, and it was found that PVT1 inhibited the expression of TGF-β, suggesting that PVT1 may regulate the occurrence and development of hypopharyngeal carcinoma FaDu cells through TGF-β.
下咽癌是头颈部恶性肿瘤之一,预后尤其差。复发和转移是下咽癌患者预后不良的重要原因,而肿瘤细胞的恶性增殖、迁移和侵袭是下咽癌复发和转移的重要因素。因此,阐明下咽癌细胞的增殖、迁移和侵袭机制对于提高诊断、治疗和预后至关重要。浆细胞瘤变异易位 1(PVT1)被认为是肿瘤的一个有潜力的诊断标志物和治疗靶点。然而,PVT1 是否与下咽癌的发生发展有关及其具体机制尚不清楚。在本研究中,通过细胞生物学实验和动物研究验证了 PVT1 对下咽癌 FaDu 细胞增殖、迁移和侵袭的促进作用,并发现 PVT1 抑制了 TGF-β 的表达,提示 PVT1 可能通过 TGF-β 调节下咽癌 FaDu 细胞的发生发展。